Abstract
RovA is known to enhance Yersinia pestis virulence by directly upregulating the psa loci. This work presents a complex gene regulatory paradigm involving the reciprocal regulatory action of RovM and RovA on the expression of biofilm and virulence genes as well as on their own genes. RovM and RovA enhance and inhibit Y. pestis biofilm production, respectively, whereas RovM represses virulence in mice. RovM directly stimulates the transcription of hmsT, hmsCDE and rovM, while indirectly enhancing hmsHFRS transcription. It also indirectly represses hmsP transcription. By contrast, RovA directly represses hmsT transcription and indirectly inhibits waaAE-coaD transcription, while RovM inhibits psaABC and psaEF transcription by directly repressing rovA transcription. rovM expression is significantly upregulated at 26°C (the temperature of the flea gut) relative to 37°C (the warm-blooded host temperature). We speculate that upregulation of rovM together with downregulation of rovA in the flea gut would promote Y. pestis biofilm formation while inhibiting virulence gene expression, leading to a more transmissible infection of this pathogen in fleas. Once the bacterium shifts to a lifestyle in the warm-blooded hosts, inhibited RovM production accompanied by recovered RovA synthesis would encourage virulence factor production and inhibit biofilm gene expression.
Keywords: Yersinia pestis, RovM, RovA, biofilm, virulence, transcriptional regulation
1. Introduction
Yersinia pestis, the causative agent of plague, has caused at least three plague pandemics in human history. The transmission of bubonic and septicaemic plague in nature primarily relies on infected fleas. Y. pestis grows as an attached biofilm that blocks the flea's proventriculus, which enhances the flea-borne transmission of this pathogen [1].
The Y. pestis hmsHFRS operon is responsible for the synthesis and transport of exopolysaccharide, the primary dry component of the biofilm matrix [2]. 3,5′-cyclic diguanylic acid (c-di-GMP) is a signalling molecule that promotes biofilm exopolysaccharide production in bacteria. In Y. pestis, HmsT and HmsD (hmsD is located in the three-gene operon hmsCDE) are the only two diguanylate cyclases that catalyse c-di-GMP synthesis [3], whereas HmsP is the sole phosphodiesterase catalysing c-di-GMP degradation [4].
waaA, waaE and coaD constitute the three-gene operon waaAE-coaD in Y. pestis; WaaA is a 3-deoxy-d-manno-octulosonic acid transferase involved in the synthesis of lipopolysaccharide (LPS), and the deletion of waaA leads to a biofilm defect phenotype of Y. pestis [5]. The waaAE-coaD operon is necessary for the biosynthesis of integral LPS, and the truncation of LPS owing to the deletion of waaA in Y. pestis induces dramatic attenuation of virulence [6].
Yersinia pestis psa loci are composed of two adjacent operons: psaABC and psaEF [7]. psaA is the structural gene of the pH 6 antigen, a PsaA polymer fimbrial structure; PsaB and PsaC constitute a chaperone/usher machinery that mediates the secretion and assembly of pH 6 antigen on the cell surface [7]. psaABC expression is greatly stimulated following a rise in temperature from 26°C to 37°C and in acidic environments, whereas psaEF encodes the transcriptional activators of psaABC [8]. pH 6 antigen is an adhesin that mediates the entry of bacteria into human pulmonary epithelial cells [9,10]. It is also critical for contact of Y. pestis with eukaryotic cells that promotes the delivery of Yops (effectors of plasmid pCD1-encoding type III secretion system) to target host cells [11]. A further pH 6 function is as an anti-phagocytic factor, independent of Yops and the F1 capsule, which blocks bacterial uptake [12]. However, the loss of pH 6 antigen production has no effect on Y. pestis virulence in subcutaneously inoculated BALB/c naive mice [13]. Involvement of pH 6 antigen in Y. pestis virulence seems to rely on Y. pestis strains and animals challenged.
The ferric uptake regulator Fur controls almost all iron assimilation functions in Y. pestis [14], and also acts as a strong repressor of Y. pestis biofilm formation through direct inhibition of hmsT transcription [15].
phoP and phoQ can be assigned into two operons: YPO1635-phoPQ-YPO1632 and phoPQ-YPO1632 [16]. The regulator PhoP and sensor PhoQ constitute a two-component regulatory system, PhoP/PhoQ. PhoP/PhoQ production is induced in the flea gut, and is essential for the formation of flea-borne infectious Y. pestis biofilms [17]. PhoP has no regulatory effect on hms genes, but it acts as a direct transcriptional activator of waaAE-coaD [18].
RovA is required for full virulence in all three pathogenic Yersinia species [19–21]. Y. pestis RovA stimulates transcription of the CUS-2 loci [19], which encode a stably integrated prophage in the Orientalis biovars, but not in the other three biovars Antiqua, Medievalis and Microtus. This prophage is not associated with biofilm formation or flea transmission, but contributes to virulence in mice [22]. RovA also plays a critical role in modulating construction and functioning of the Y. pestis cell membrane [23]. Most importantly, Y. pestis PhoP and RovA bind to the promoter–proximal regions of psaABC and psaEF to repress and stimulate their transcription, respectively. PhoP directly represses rovA transcription, thereby directly and indirectly negatively regulating psa genes though acting on both psa genes and rovA [24,25].
RovM is a LysR-type transcription factor that directly inhibits rovA transcription in Y. pseudotuberculosis, which is genetically closely related to Y. pestis [26]. A set of LysR-family regulators, such as PecT in Erwinia chrysanthemi, HexA in E. carotovora, LrhA in Escherichia coli and YfbA in Y. pestis [27], were found to modulate bacterial virulence and biofilm formation [28–30]. However, it remains unknown whether RovM controls virulence and biofilm gene expression in Y. pestis. Similarly, an array of MarR-family regulators, such as TcaR in Staphylococcus epidermidis, AsrR in Enterococcus faecium, RcaR in Streptococcus mutans and SarZ/SarA in Staphylococcus aureus, were reported to affect biofilm formation [31–34]. RovA is another MarR-family regulator, but it is not clear whether Y. pestis RovA is involved in the modulation of biofilm production.
This work presents a complex gene regulatory paradigm involving the reciprocal regulatory action of RovM and RovA on biofilm formation, virulence in mice and their own expression in Y. pestis, promoting us to gain deeper insights into coordinative modulation of virulence and biofilm gene expression during lifestyle shift between flea vectors and warm-blooded mammalian hosts (figure 1).
Figure 1.

Reciprocal regulation of biofilm formation and virulence by RovM and RovA. (a) Gene regulatory paradigm. The gene regulatory circuits are described in the main text; those highlighted in red correspond to data presented in this work, whereas those in blue were characterized previously. (b) Coordinative modulation of virulence and biofilm gene expression. The proposed model of coordinative modulation of virulence and biofilm gene expression during the lifestyle shift between flea vectors and warm-blooded mammalian hosts is shown. Grey lines indicate inhibited gene expression or regulatory actions that have stopped.
2. Results
2.1. RovM- and RovA-dependent biofilm and virulence phenotypes
The deletion of rovM induced a dramatic reduction of biofilm crystal violet staining compared with wild-type (WT) and C-rovM; by contrast, ΔrovA showed more crystal violet staining than WT and C-rovA (figure 2a). After incubation of nematode eggs on the bacterial lawns of ΔhmsS, 100% of the larvae grew and developed into L4/adult nematodes, whereas values for WT/C-rovM/C-rovA, ΔrovM and ΔrovA lawns were 15%, 40% and 2%, respectively (figure 2b). When grown on LB agar plates, ΔrovM colony morphology was much smoother than that of WT and C-rovM, whereas ΔrovA morphology was more rugose than that of WT and C-rovA (figure 2c). A significantly lower production of cellular c-di-GMP was observed in ΔrovM relative to WT and C-rovM, but this was much higher in ΔrovA compared with WT and C-rovA (figure 2d). These phenotypic results suggest that the deletion of rovM or rovA led to a dramatic reduction or elevation of biofilm/c-di-GMP production, respectively. Additionally, compared with WT and C-rovM, ΔrovM displayed a significant increase in virulence in mice after subcutaneous (s.c.) or intravenous (i.v.) injection (figure 2e,f). Our previous study showed that the deletion of rovA induced a significant virulence attenuation of Y. pestis strain 201 after s.c. or i.v. injection [23]. In summary, Y. pestis RovM and RovA appear to enhance and inhibit biofilm formation, respectively, while also inhibiting and enhancing virulence, respectively.
Figure 2.
RovM- and RovA-dependent phenotypes. (a) Crystal violet staining of biofilms. Y. pestis was grown in 24-well polystyrene dishes, and the bacterial biomass adhering to the well walls was stained with crystal violet to determine the OD570 values. Planktonic cells were used to determine OD620 values. The relative capacity of biofilm formation of each strain tested was shown as the OD570/OD620 value. (b) Biofilms on nematodes. After the incubation of nematode eggs on the lawns of indicated Y. pestis strains, the nematode developmental stage on each lawn was scored to calculate the percentage of L4/adult. (c) Bacterial colony morphology. Aliquots of bacterial glycerol stocks were spotted onto LB plates, and incubated for one week. (d) Cellular c-di-GMP concentrations. Intracellular c-di-GMP concentrations were determined by high-performance liquid chromatography with tandem mass spectrometry, and values expressed as pmol mg−1 of bacterial protein. (e,f) Virulence in mice. BALB/c mice were challenged with approximately 300 CFU of each of WT, ΔrovM or C-rovM via s.c. (e) or i.v. (f) routes of infection.
The first genes of the indicated multi-gene operons as well as the individual genes, which encode major biofilm determinants (hmsT, hmsCDE, hmsHFRS, hmsP and waaAE-coaD), the virulence factor pH 6 antigen and its local regulators (psaABC and psaEF), and a set of global regulators involved in biofilm and virulence modulation (YPO1635-phoPQ-YPO1632, phoPQ-YPO1632, fur, rovA and rovM), were subjected to the following gene regulation experiments to dissect the detailed regulatory action of RovM and RovA on these target genes.
2.2. Regulation of major biofilm genes by RovM and RovA
As indicated by the primer extension and real-time reverse transcriptase (RT)-PCR assays, mRNA levels of each of hmsT (figure 3a,b), hmsC (electronic supplementary material, figure S1a,b) and hmsH (figure 4a,b) were reduced in ΔrovM relative to WT, while that of hmsP (electronic supplementary material, figure S2a,b) was enhanced in ΔrovM relative to WT. The LacZ fusion assay revealed that the promoter activity of each of hmsT (figure 3c), hmsC (electronic supplementary material, figure S1c) and hmsH (figure 4c) was attenuated in ΔrovM relative to WT, but that of hmsP (electronic supplementary material, figure S2c) was elevated in ΔrovM relative to WT. By contrast, the primer extension, real-time RT-PCR and LacZ fusion experiments showed that RovM had no regulatory action on waaA at the transcriptional level (electronic supplementary material, figure S3a–c). The electrophoretic mobility shift assay (EMSA) revealed that His-RovM could bind in a dose-dependent manner to the promoter–proximal regions of hmsT (figure 3d) and hmsC (electronic supplementary material, figure S1d) but not to hmsH (figure 4d), hmsP (electronic supplementary material, figure S2d) or waaA (electronic supplementary material, figure S3d).
Figure 3.
Direct activation of hmsT transcription by RovM. Positive and negative numbers indicate the nucleotide positions upstream and downstream of the translation start site, respectively. Lanes G, A, T and C represent Sanger sequencing reactions. (a) Primer extension. An oligonucleotide primer was designed to be complementary to the RNA transcript of hmsT. Primer extension products were analysed with an 8 M urea–6% acrylamide sequencing gel. Arrow represents the transcription start site of hmsT. (b) Quantitative RT-PCR. mRNA levels of hmsT were compared between ΔrovM and WT. A standard curve was made for each RNA preparation with the 16S rRNA gene; the relative mRNA level was determined by calculating the threshold cycle (ΔCt) of target genes via the classic ΔCt method. (c) LacZ fusion. A promoter–proximal region of hmsT was cloned into the lacZ transcriptional fusion vector pRW50, and transformed into WT or ΔrovM to determine hmsT promoter activity, i.e. β-galactosidase activity (Miller units), in cellular extracts. (d) EMSA. The radioactively labelled promoter–proximal DNA fragment of hmsT was incubated with increasing amounts of purified His-RovM protein, then subjected to 4% (w/v) polyacrylamide gel electrophoresis. With increasing amounts of His-RovM, the band of free target DNA disappeared, and a retarded DNA band with decreased mobility was apparent, which presumably represented the protein–DNA complex. A DNA fragment from the coding region of the 16S rRNA gene served as a negative control.
Figure 4.
Indirect activation of hmsH transcription by RovM. See figure 3 for the annotations of primer extension (a), quantitative RT-PCR (b), LacZ fusion (c) and EMSA (d).
The primer extension, real-time RT-PCR and LacZ fusion assays also indicated that the transcription of hmsT (electronic supplementary material, figure S4a–c) and waaA (electronic supplementary material, figure S5a–c) was enhanced in ΔrovA relative to WT, but that the rovA deletion did not influence the transcription of hmsC (electronic supplementary material, figure S6a–c), hmsH (electronic supplementary material, figure S7a–c) or hmsP (electronic supplementary material, figure S8a–c). The EMSA assay indicated that His-RovA only bound in a dose-dependent manner to the promoter–proximal region of hmsT (electronic supplementary material, figure S4d), and not to all the other target genes tested (electronic supplementary material, figure S5d,S6d,S7d,S8d).
In summary, RovM directly stimulates the transcription of hmsT and hmsCDE and also indirectly promotes hmsHFRS transcription; meanwhile, it indirectly represses hmsP transcription. RovA directly represses hmsT transcription and also indirectly inhibits waaAE-coaD transcription. Moreover, RovM has no regulatory effect on waaAE-coaD at the transcriptional level, and RovA does not regulate the transcription of hmsCDE, hmsHFRS or hmsP.
2.3. Regulation of virulence-related psa loci by RovM
The primer extension, real-time RT-PCR and LacZ fusion assays disclosed that the transcription of psaA (electronic supplementary material, figure S9a–c) and psaE (electronic supplementary material, figure S10a–c) was enhanced in ΔrovM relative to WT. The EMSA assay showed that His-RovM could not bind to the promoter–proximal regions of psaA (electronic supplementary material, figure S9d) or psaE (electronic supplementary material, figure S10d), suggesting that the inhibition of psaABC and psaEF transcription by RovM is indirect.
2.4. Regulation of regulatory genes by RovM and RovA
The primer extension, real-time RT-PCR and LacZ fusion assays showed that the rovM deletion led to an elevated transcription of YPO1635 (electronic supplementary material, figure S11a–c) but had no effect on the transcription of phoP (electronic supplementary material, figure S12a–c) or fur (electronic supplementary material, figure S13a–c). The EMSA assay found that His-RovM could not bind to the promoter–proximal region of YPO1635 (electronic supplementary material, figure S11d), phoP (electronic supplementary material, figure S12d) or fur (electronic supplementary material, figure S13d). Therefore, RovM indirectly inhibits the transcription of YPO1635-phoPQ-YPO1632, but it has no regulatory effect on phoPQ-YPO1632 or fur at the transcriptional level.
The primer extension assay detected three different transcriptional start sites for rovA, located at 78, 100 and 343 bp upstream of rovA, respectively; therefore, three distinct promoters (designated P1–P3, respectively) were transcribed for rovA. The rovM deletion resulted in enhanced P1 and P2 activity, but did not influence P3 activity (electronic supplementary material, figure S14a). The negative regulation of rovA by RovM was further confirmed by real-time RT-PCR (electronic supplementary material, figure S14b) and LacZ fusion (electronic supplementary material, figure S14c). The EMSA assay detected the dose-dependent binding of His-RovM to the rovA promoter–proximal fragment (electronic supplementary material, figure S14d). Therefore, RovM recognizes the rovA upstream DNA region in its inhibition of rovA transcription.
The primer extension and LacZ fusion assays could not detect a difference in rovM expression between WT and ΔrovM (data not shown). To further characterize the potential RovM autoregulation, we constructed a rovM-overexpressing strain, WT/pBAD33-rovM, as well as the empty vector control strain, WT/pBAD33. The real-time RT-PCR assay validated the dramatically elevated mRNA expression of rovM in WT/pBAD33-rovM relative to WT/pBAD33 (figure 5a). Crystal violet staining and bacterial colony morphology assays further confirmed that rovM overexpression in WT/pBAD33-rovM led to enhanced biofilm production of this strain compared with WT/pBAD33 (figure 5b,c). The subsequent primer extension (figure 5d) and LacZ fusion assays (figure 5e) with WT/pBAD33-rovM and WT/pBAD33 revealed the positive regulatory action of RovM on its own gene. The EMSA assay detected the dose-dependent binding of His-RovM to the rovM promoter–proximal fragment (figure 5f). Therefore, RovM has an autostimulatory effect though binding to the upstream DNA region of its own gene.
Figure 5.
RovM upregulates its own gene. See figure 3 for the annotations of quantitative RT-PCR (a), primer extension (d), LacZ fusion (e) and EMSA (f). See figure 2 for the annotations of crystal violet staining of biofilms (b) and bacterial colony morphology (c).
Similarly, the rovA deletion led to the elevated transcription of YPO1635 (electronic supplementary material, figure S15a–c) and phoP (electronic supplementary material, figure S16a–c), but had no effect on the transcription of fur (electronic supplementary material, figure S17a–c) or rovM (electronic supplementary material, figure S18a–c). His-RovA could not bind to the promoter–proximal region of YPO1635 (electronic supplementary material, figure S15d), phoP (electronic supplementary material, figure S16d), fur (electronic supplementary material, figure S17d) or rovM (electronic supplementary material, figure S18d). Therefore, RovA indirectly represses the transcription of YPO1635-phoPQ-YPO1632 and phoPQ-YPO1632, but it does not regulate fur and rovM. The RovA concentration-dependent positive and negative regulation of its own gene has been described in our previous work [25].
2.5. Upregulation of rovM at 26°C relative to 37°C
The primer extension and real-time RT-PCR assays showed that the mRNA level of rovM was decreased following the shift of growth temperature from 26°C to 37°C (electronic supplementary material, figure S19a and S19b), which was further confirmed by the LacZ fusion experiments (electronic supplementary material, figure S19c). Thus, rovM transcription is upregulated at 26°C relative to 37°C.
The primer extension and LacZ fusion experiments were carried out using WT, ΔrovM, C-rovM, ΔrovA and C-rovA to characterize RovM- and RovA-dependent expression of hmsT; as expected, RovM and RovA promoted and repressed the transcription of hmsT, respectively, while the detected mRNA levels and promoter activities of hmsT were comparable between WT, C-rovM and C-rovA (electronic supplementary material, figure S20), confirming that the rovM or rovA mutation was non-polar.
3. Discussion
Data presented here (figure 1a) show that Y. pestis RovM inhibits virulence in mice, most likely through the direct repression of the transcription of rovA, which encodes a transcriptional activator of multiple virulence genes including the psa loci. Additionally, RovM promotes biofilm/c-di-GMP production by directly stimulating the transcription of hmsT and hmsCDE, and upregulates hmsHFRS transcription and simultaneously downregulates hmsP transcription, both in an indirect manner. RovM appears to be a master activator of Y. pestis biofilm production because it is able to modulate all four major biofilm gene loci, hmsT, hmsCDE, hmsHFRS and hmsP. By contrast, RovA inhibits Y. pestis biofilm formation through directly repressing hmsT transcription and indirectly downregulating waaAE-coaD, YPO1635-phoPQ-YPO1632 and phoPQ-YPO1632. waaAE-coaD transcription is known to be directly activated by PhoP [18]. Unlike its homologue in Salmonella [35], Y. pestis RovA cannot bind to the promoter region of either YPO1635-phoPQ-YPO1632 or phoPQ-YPO1632. RovA probably represses the transcription of YPO1635-phoPQ-YPO1632 and phoPQ-YPO1632 via acting on other protein or non-coding RNA regulators.
The upregulation of rovM accompanied by the downregulation of rovA has previously been reported in the flea gut [36]. As shown in this work, rovM expression is significantly upregulated at 26°C (flea gut temperature) relative to 37°C (warm-blooded host temperature). RovM appears to sense temperature signals to upregulate its own gene expression and in turns inhibits rovA expression in the flea gut. The elevated RovM production in the flea gut will promote the synthesis of attached biofilms and inhibit virulence gene expression, facilitating the establishment of a transmissible infection in fleas. Then, once the bacterium shifts to a lifestyle in the warm-blooded hosts, RovM production is decreased and RovA synthesis initiated, which in turn drives virulence factor synthesis and inhibits biofilm gene expression (figure 1b). Notably, cellular RovM levels were not shown to change following a temperature shift from 37°C and 26°C in Y. pseudotuberculosis [26], and the temperature-dependent rovM expression might be an example of favourable evolution to promote Y. pestis transmission via fleas.
It was recently reported that the deletion of rovM in Y. pestis did not affect biofilm formation and flea gut blockage [37]. Notably, the authors of this study used a low-virulence derivative of strain KIM, designated KIM6+, which lacks pCD1 [37]. This compares with the WT strain 201 in the presence of pCD1 that was used in this study. Previously, use of a pCD1-cured derivative of strain CO92 resulted in the negative regulation of biofilm formation by Hfq through promoting hmsP mRNA accumulation and simultaneously decreasing hmsT transcript stability [38]; this was confirmed using pCD1-cured strain 201 (2016, unpublished data). However, the use of WT strain 201 produced the opposite result, in which Hfq enhanced biofilm formation through positively regulating hmsT, hmsCDE and hmsHFRS and negatively regulating hmsP (2016, unpublished data). Similarly, the presence and absence of pCD1 resulted in the observation of opposite phenotypes of poly-N-acetylglucosamine production [39]. Y. pestis genetic backgrounds (e.g. presence or absence of pCD1) and even bacterial cultivation conditions would alter the relevant regulatory pathways of Y. pestis biofilm formation.
4. Material and methods
4.1. Bacterial strains and growth
The WT Y. pestis biovar Microtus strain 201 is avirulent to humans but highly lethal to mice [40]. Base pairs 41–362 of rovA (total length, 432 bp) or the entire coding region of rovM was replaced by the kanamycin resistance cassette using the one-step inactivation method based on the lambda phage recombination system. This generated the Y. pestis rovA and rovM null mutants (designated ΔrovA or ΔrovM, respectively). All primers used in this study are listed in the electronic supplementary material, table S1. Y. pestis ΔhmsS [41] was used as a reference biofilm-defective strain.
A PCR-generated DNA fragment containing the rovA or rovM coding region with its approximately 500 bp upstream promoter–proximal region and approximately 300 bp downstream transcriptional terminator region was cloned into the pACYC184 vector (GenBank accession number X06403). The recombinant plasmid was introduced into ΔrovA or ΔrovM, yielding the complemented mutant strain C-rovA or C-rovM, respectively.
A PCR-generated DNA fragment composed of the rovM coding region together with an upstream synthetic ribosome binding site (AGGAGGAATTCACC) was cloned between the XbaI and HindIII sites of the pBAD33 vector [42] harbouring an arabinose PBAD promoter and a chloramphenicol resistance gene. Upon being verified by DNA sequencing, the recombinant plasmid pBAD33-rovM was introduced into WT through electrotransformation, yielding the rovM-overexpressed strain WT/pBAD33-rovM. The empty vector pBAD33 was also introduced into WT to generate WT/pBAD33.
4.2. Bacterial growth and RNA isolation
For psaABC-related gene regulation experiments, SBHI broth (3.7% Bacto Brain Heart Infusion (BD Biosciences), 0.5% Oxoid yeast extract, 2.5 mM CaCl2, 0.2% xylose, pH 6.0) was used for bacterial cultivation [43]. An overnight bacterial culture with an optical density (OD620) value of about 1.0 was diluted 1 : 20 into fresh SBHI for further growth at 26°C with shaking at 230 r.p.m. The cell culture with an OD620 of about 0.6 was transferred to 37°C, and then allowed to grow for a further 3 h prior to cell harvest.
For rovM autoregulation-related gene regulation and phenotypic experiments, an overnight cell culture in Luria–Bertani (LB) broth with an OD620 of about 1.0 was diluted 1 : 20 into fresh LB broth for further cultivation at 26°C to reach an OD620 of about 0.6. Then, 0.2% arabinose was added, and the culture was allowed to grow for a further 3 h.
For all other gene regulation and phenotypic assays, an overnight cell culture in LB broth with an OD620 of about 1.0 was diluted 1 : 20 into fresh LB broth for further cultivation at 26°C to reach an OD620 of about 1.0. To elicit a temperature upshift from 26°C to 37°C (for monitoring rovM regulation), half of the cell cultures were incubated at 37°C for 3 h while the remaining half were allowed to grow continuously at 26°C for 3 h prior to cell harvest.
Before the bacterial harvest, double-volume RNAprotect Bacteria Reagent (Qiagen) was added immediately to the cell culture. Total bacterial RNAs were extracted using TRIzol Reagent (Invitrogen) [15,16]. The RNA quality was monitored by agarose gel electrophoresis, and its quantity was determined by spectrophotometry.
4.3. Primer extension assay
For the primer extension assay [15,16], an oligonucleotide primer complementary to a portion of the RNA transcript of each indicated gene was used to synthesize cDNAs from RNA templates. About 10 µg of total RNA from each strain was annealed with 1 pmol of [γ-32P] end-labelled reverse primer using a Primer Extension System (Promega) according to the manufacturer's instructions. The same labelled primer was also used for sequencing with the fmol® DNA Cycle Sequencing System (Promega). The primer extension products and sequencing materials were concentrated and analysed in a 6% polyacrylamide/8 M urea gel. The result was detected by autoradiography (Kodak film).
4.4. Quantitative RT-PCR
Gene-specific primers were designed to produce amplicons for target genes. Contaminating DNA in the RNA samples was removed using the Ambion DNA-free™ Kit (Applied Biosystems). cDNAs were generated by using 5 µg of RNA and 3 µg of random hexamer primers. Real-time PCR was performed using the LightCycler system (Roche) and the SYBR Green master mix [44,45]. Based on the standard curves of 16S rRNA expression, the relative mRNA level was determined by calculating the threshold cycle (ΔCt) of target genes via the classic ΔCt method. Negative controls used cDNA generated without reverse transcriptase as templates. Reactions containing primer pairs without template were also included as blank controls. The 16S rRNA gene was used as an internal control for normalization.
4.5. Lacz reporter fusion and β-galactosidase assay
The promoter–proximal DNA region of each gene tested was prepared by PCR with Takara ExTaq DNA polymerase using Y. pestis 201 genomic DNA as template. This was then cloned directionally into the HindIII–BamHI site of the transcriptional fusion vector pRW50 [46] that contained a promotorless lacZ reporter gene. The clone was verified by DNA sequencing. Each Y. pestis strain tested was transformed with the recombinant plasmids, and an empty plasmid was introduced into each strain as a negative control. β-Galactosidase activity was measured in extracts from cells cultivated as above using the β-galactosidase enzyme assay system (Promega) [15,16].
4.6. Preparation of 6× His-tagged RovA (His-RovA) and RovM (His-RovM) protein
The preparation of purified RovA [24] or RovM [26] protein was performed as previously described. The entire coding region of rovA or rovM was amplified from Y. pestis 201 or EV76, respectively, and cloned directionally into the BamHI and HindIII or BamHI and SalI sites of plasmid pET28a (Novagen), respectively. The recombinant plasmids were transformed into E. coli BL21 (DE3) cells (Novagen). Expression of His-RovA or His-RovM protein was induced by the addition of 1 mM or 2 mM isopropyl-beta-d-thiogalactoside, respectively. His-RovA or His-RovM were purified under native conditions using QIAexpressionist™ Ni–NTA affinity chromatography (Qiagen). The purified, eluted protein was concentrated with the Amicon Ultra-15 (Millipore) to a final concentration of 0.5–0.7 mg ml−1 in the storage buffer containing phosphate-buffered saline (PBS, pH 8.0) plus 20% glycerol. The protein purity was verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis with silver staining.
4.7. Electrophoretic mobility shift assay
For EMSA [15,16], promoter–proximal DNA regions were prepared by PCR amplification. EMSA was performed using the Gel Shift Assay Systems (Promega). The 5′ ends of DNA were labelled using [γ-32P] ATP and T4 polynucleotide kinase. DNA binding was performed in a 10 µl volume containing binding buffer (100 µM MnCl2, 1 mM MgCl2, 0.5 mM DTT, 50 mM KCl, 10 mM Tris–HCl (pH 7.5), 0.05 mg ml−1 sheared salmon sperm DNA, 0.05 mg ml−1 BSA and 4% glycerol), labelled DNA (1000–2000 c.p.m µl−1) and increasing amounts of His-RovA or His-RovM. We included two control reactions: one contained the specific DNA competitor (unlabelled promoter DNA regions; cold probe), whereas the other was the non-specific protein competitor (rabbit anti-F1-protein polyclonal IgG antibody). After incubation at room temperature for 30 min, the products were loaded onto a native 4% (w/v) polyacrylamide gel and electrophoresed in 0.5× Tris–borate buffer containing 100 µM MnCl2 for 30 min at 220 V. Radioactive species were detected by autoradiography.
4.8. Biofilm-related assays
Four different methods [47,48] of biofilm-related assays were used (i) crystal violet staining of the in vitro biofilm masses attached to the well walls when bacteria were grown in polystyrene microtitre plates; (ii) determination of the percentages of fourth-stage larvae and adults (L4/adult) of Caenorhabditis elegans after the incubation of nematode eggs on Y. pestis lawns, which negatively reflected the bacterial ability to produce biofilms; (iii) observation of the rugose colony morphology of bacteria grown on LB agar plates, which positively reflected the bacterial ability to synthesize biofilm matrix exopolysaccharide; and (iv) determination of intracellular c-di-GMP levels by a chromatography-coupled tandem mass spectrometry method.
4.9. Murine infection model
All animal experiments were conducted in accordance with Guidelines for Welfare and Ethics of Laboratory Animals of China. Bacterial cultures were washed twice with PBS (pH 7.2), and then subjected to serial 10-fold dilutions with PBS. Appropriate dilutions were plated onto He's agar plates (LandBridge) to calculate the numbers of colony-forming units (CFU). For each strain tested, 0.1 ml of the 103 CFU ml−1 bacterial suspension was inoculated by s.c. injection at the inguinal region or by i.v. injection via the vena caudalis into each of 10 female BALB/c mice (aged six to eight weeks old). The numbers of mice that died at specified times were then calculated and used to draw a survival curve with GraphPad Prism v. 5.0. p-Values were calculated with the log-rank (Mantel–Cox) test and the Gehan–Breslow–Wilcoxon test; p < 0.01 was considered to indicate statistical significance.
4.10. Experimental replicates and statistical methods
For real-time RT-PCR, LacZ fusion, crystal violet staining of biofilms, and the determination of L4/adult nematodes or c-di-GMP, experiments were performed with at least three independent bacterial cultures/lawns, and values were expressed as mean ± standard deviation. The paired Student's t-test was performed to determine significant differences; p < 0.01 was considered to indicate statistical significance. For primer extension, EMSA and colony morphology observation, representative data from at least two independent biological replicates are shown.
Supplementary Material
Authors' contributions
D.Z. and R.Y. conceived the study and designed experimental procedures; L.L., H.F., H.Y., Y.Z. and Y.H. performed the experiments and carried out data analysis; D.Z., L.L. and R.Y. wrote the paper.
Competing interests
The authors declare that no conflict of interest exists.
Funding
This work was supported by the National Natural Science Foundation of China (31430006, 31471184 and 81302608), the National Basic Research Programme of China (2015CB554202), the Foundation of State Key Laboratory of Pathogen and Biosecurity of China (SKLPBS1402) and the China Postdoctoral Science Foundation (2015M572755).
References
- 1.Zhou D, Yang R. 2011. Formation and regulation of Yersinia biofilms. Protein Cell 2, 173–179. (doi:10.1007/s13238-011-1024-3) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bobrov AG, Kirillina O, Forman S, Mack D, Perry RD. 2008. Insights into Yersinia pestis biofilm development: topology and co-interaction of Hms inner membrane proteins involved in exopolysaccharide production. Environ. Microbiol. 10, 1419–1432. (doi:10.1111/j.1462-2920.2007.01554.x) [DOI] [PubMed] [Google Scholar]
- 3.Bobrov AG, et al. 2011. Systematic analysis of cyclic di-GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis. Mol. Microbiol. 79, 533–551. (doi:10.1111/j.1365-2958.2010.07470.x) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kirillina O, Fetherston JD, Bobrov AG, Abney J, Perry RD. 2004. HmsP, a putative phosphodiesterase, and HmsT, a putative diguanylate cyclase, control Hms-dependent biofilm formation in Yersinia pestis. Mol. Microbiol. 54, 75–88. (doi:10.1111/j.1365-2958.2004.04253.x) [DOI] [PubMed] [Google Scholar]
- 5.Tan L, Darby C. 2005. Yersinia pestis is viable with endotoxin composed of only lipid A. J. Bacteriol. 187, 6599–6600. (doi:10.1128/JB.187.18.6599-6600.2005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dentovskaya SV, et al. 2011. Functional characterization and biological significance of Yersinia pestis lipopolysaccharide biosynthesis genes. Biochemistry 76, 808–822. (doi:10.1134/S0006297911070121) [DOI] [PubMed] [Google Scholar]
- 7.Gao H, et al. 2008. The iron-responsive Fur regulon in Yersinia pestis. J. Bacteriol. 190, 3063–3075. (doi:10.1128/JB.01910-07) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sun F, et al. 2012. Fur is a repressor of biofilm formation in Yersinia pestis. PLoS ONE 7, e52392 (doi:10.1371/journal.pone.0052392) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Price SB, Freeman MD, Yeh KS. 1995. Transcriptional analysis of the Yersinia pestis pH 6 antigen gene. J. Bacteriol. 177, 5997–6000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yang Y, Isberg RR. 1997. Transcriptional regulation of the Yersinia pseudotuberculosis pH 6 antigen adhesin by two envelope-associated components. Mol. Microbiol. 24, 499–510. (doi:10.1046/j.1365-2958.1997.3511719.x) [DOI] [PubMed] [Google Scholar]
- 11.Liu F, Chen H, Galvan EM, Lasaro MA, Schifferli DM. 2006. Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells. Infect. Immun. 74, 5636–5644. (doi:10.1128/IAI.00612-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Galvan EM, Chen H, Schifferli DM. 2007. The Psa fimbriae of Yersinia pestis interact with phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant. Infect. Immun. 75, 1272–1279. (doi:10.1128/IAI.01153-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Felek S, Tsang TM, Krukonis ES. 2010. Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence. Infect. Immun. 78, 4134–4150. (doi:10.1128/IAI.00167-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Huang XZ, Lindler LE. 2004. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen. Infect. Immun. 72, 7212–7219. (doi:10.1128/IAI.72.12.7212-7219.2004) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Anisimov AP, et al. 2009. The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice. J. Med. Microbiol. 58, 26–36. (doi:10.1099/jmm.0.005678-0) [DOI] [PubMed] [Google Scholar]
- 16.Zhang Y, et al. 2013. Autoregulation of PhoP/PhoQ and positive regulation of the cyclic AMP receptor protein-cyclic AMP complex by PhoP in Yersinia pestis. J. Bacteriol. 195, 1022–1030. (doi:10.1128/JB.01530-12) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rebeil R, Jarrett CO, Driver JD, Ernst RK, Oyston PC, Hinnebusch BJ. 2013. Induction of the Yersinia pestis PhoP-PhoQ regulatory system in the flea and its role in producing a transmissible infection. J. Bacteriol. 195, 1920–1930. (doi:10.1128/JB.02000-12) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Liu L, Fang N, Sun Y, Yang H, Zhang Y, Han Y, Zhou D, Yang R. 2014. Transcriptional regulation of the waaAE-coaD operon by PhoP and RcsAB in Yersinia pestis biovar Microtus. Protein Cell 5, 940–944. (doi:10.1007/s13238-014-0110-8) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL. 2006. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc. Natl Acad. Sci. USA 103, 13 514–13 519. (doi:10.1073/pnas.0603456103) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Dube PH, Handley SA, Revell PA, Miller VL. 2003. The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection. Infect. Immun. 71, 3512–3520. (doi:10.1128/IAI.71.6.3512-3520.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nagel G, Heroven AK, Eitel J, Dersch P. 2003. Function and regulation of the transcriptional activator RovA of Yersinia pseudotuberculosis. Adv. Exp. Med. Biol. 529, 285–287. (doi:10.1007/0-306-48416-1_54) [DOI] [PubMed] [Google Scholar]
- 22.Derbise A, Chenal-Francisque V, Pouillot F, Fayolle C, Prevost MC, Medigue C, Hinnebusch BJ, Carniel E. 2007. A horizontally acquired filamentous phage contributes to the pathogenicity of the plague bacillus. Mol. Microbiol. 63, 1145–1157. (doi:10.1111/j.1365-2958.2006.05570.x) [DOI] [PubMed] [Google Scholar]
- 23.Yang F, et al. 2010. Cell membrane is impaired, accompanied by enhanced type III secretion system expression in Yersinia pestis deficient in RovA regulator. PLoS ONE 5, e12840 (doi:10.1371/journal.pone.0012840) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang Y, Wang L, Fang N, Qu S, Tan Y, Guo Z, Qiu J, Zhou D, Yang R. 2013. Reciprocal regulation of pH 6 antigen gene loci by PhoP and RovA in Yersinia pestis biovar Microtus. Fut. Microbiol. 8, 271–280. (doi:10.2217/fmb.12.146) [DOI] [PubMed] [Google Scholar]
- 25.Zhang Y, Gao H, Wang L, Xiao X, Tan Y, Guo Z, Zhou D, Yang R. 2011. Molecular characterization of transcriptional regulation of rovA by PhoP and RovA in Yersinia pestis. PloS ONE 6, e25484 (doi:10.1371/journal.pone.0025484) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Heroven AK, Dersch P. 2006. RovM, a novel LysR-type regulator of the virulence activator gene rovA, controls cell invasion, virulence and motility of Yersinia pseudotuberculosis. Mol. Microbiol. 62, 1469–1483. (doi:10.1111/j.1365-2958.2006.05458.x) [DOI] [PubMed] [Google Scholar]
- 27.Tam C, Demke O, Hermanas T, Mitchell A, Hendrickx AP, Schneewind O. 2014. YfbA, a Yersinia pestis regulator required for colonization and biofilm formation in the gut of cat fleas. J. Bacteriol. 196, 1165–1173. (doi:10.1128/JB.01187-13) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Blumer C, et al. 2005. Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli. Microbiology 151, 3287–3298. (doi:10.1099/mic.0.28098-0) [DOI] [PubMed] [Google Scholar]
- 29.Condemine G, Castillo A, Passeri F, Enard C. 1999. The PecT repressor coregulates synthesis of exopolysaccharides and virulence factors in Erwinia chrysanthemi. Mol. Plant–Microbe Interact. 12, 45–52. (doi:10.1094/MPMI.1999.12.1.45) [DOI] [PubMed] [Google Scholar]
- 30.Harris SJ, Shih YL, Bentley SD, Salmond GP. 1998. The hexA gene of Erwinia carotovora encodes a LysR homologue and regulates motility and the expression of multiple virulence determinants. Mol. Microbiol. 28, 705–717. (doi:10.1046/j.1365-2958.1998.00825.x) [DOI] [PubMed] [Google Scholar]
- 31.Chang YM, Ho CH, Chen CK, Maestre-Reyna M, Chang-Chien MW, Wang AH. 2014. TcaR-ssDNA complex crystal structure reveals new DNA binding mechanism of the MarR family proteins. Nucleic Acids Res. 42, 5314–5321. (doi:10.1093/nar/gku128) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lebreton F, et al. 2012. AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLoS Pathog. 8, e1002834 (doi:10.1371/journal.ppat.1002834) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Seaton K, Ahn SJ, Sagstetter AM, Burne RA. 2011. A transcriptional regulator and ABC transporters link stress tolerance, (p)ppGpp, and genetic competence in Streptococcus mutans. J. Bacteriol. 193, 862–874. (doi:10.1128/JB.01257-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tamber S, Cheung AL. 2009. SarZ promotes the expression of virulence factors and represses biofilm formation by modulating SarA and agr in Staphylococcus aureus. Infect. Immun. 77, 419–428. (doi:10.1128/IAI.00859-08) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Song H, Kong W, Weatherspoon N, Qin G, Tyler W, Turk J, Curtiss R III, Shi Y. 2008. Modulation of the regulatory activity of bacterial two-component systems by SlyA. J. Biol. Chem. 283, 28 158–28 168. (doi:10.1074/jbc.M801058200) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Vadyvaloo V, Jarrett C, Sturdevant DE, Sebbane F, Hinnebusch BJ. 2010. Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis. PLoS Pathog. 6, e1000783 (doi:10.1371/journal.ppat.1000783) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Vadyvaloo V, Hinz AK. 2015. A LysR-type transcriptional regulator, RovM, senses nutritional cues suggesting that it is involved in metabolic adaptation of Yersinia pestis to the flea gut. PLoS ONE 10, e0137508 (doi:10.1371/journal.pone.0137508) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bellows LE, Koestler BJ, Karaba SM, Waters CM, Lathem WW. 2012. Hfq-dependent, co-ordinate control of cyclic diguanylate synthesis and catabolism in the plague pathogen Yersinia pestis. Mol. Microbiol. 86, 661–674. (doi:10.1111/mmi.12011) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yoong P, Cywes-Bentley C, Pier GB. 2012. Poly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures. mBio 3, e00217–e00212 (doi:10.1128/mBio.00217-12) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Zhou D, et al. 2004. Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J. Bacteriol. 186, 5147–5152 (doi:10.1128/JB.186.15.5147-5152.2004) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Forman S, Bobrov AG, Kirillina O, Craig SK, Abney J, Fetherston JD, Perry RD. 2006. Identification of critical amino acid residues in the plague biofilm Hms proteins. Microbiology 152, 3399–3410. (doi:10.1099/mic.0.29224-0) [DOI] [PubMed] [Google Scholar]
- 42.Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177, 4121–4130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lindler LE, Klempner MS, Straley SC. 1990. Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect. Immun. 58, 2569–2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sun F, et al. 2014. H-NS is a repressor of major virulence gene loci in Vibrio parahaemolyticus. Front. Microbiol. 5, 675 (doi:10.3389/fmicb.2014.00675) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zhan L, et al. 2008. The cyclic AMP receptor protein, CRP, is required for both virulence and expression of the minimal CRP regulon in Yersinia pestis biovar microtus. Infect. Immun. 76, 5028–5037. (doi:10.1128/IAI.00370-08) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.El-Robh MS, Busby SJ. 2002. The Escherichia coli cAMP receptor protein bound at a single target can activate transcription initiation at divergent promoters: a systematic study that exploits new promoter probe plasmids. Biochem. J. 368, 835–843. (doi:10.1042/BJ20021003) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Fang N, Gao H, Wang L, Qu S, Zhang YQ, Yang RF, Zhou DS. 2013. Optimized methods for biofilm analysis in Yersinia pestis. Biomed. Environ. Sci. 26, 408–411. (doi:10.3967/0895-3988.2013.05.012) [DOI] [PubMed] [Google Scholar]
- 48.Fang N, Yang H, Fang H, Liu L, Zhang Y, Wang L, Han Y, Zhou D, Yang R. 2015. RcsAB is a major repressor of Yersinia biofilm development through directly acting on hmsCDE, hmsT, and hmsHFRS. Sci. Rep. 5, 9566 (doi:10.1038/srep09566) [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




